Ruffu v. Johnson & Johnson, Inc.

181 F.R.D. 341, 1998 U.S. Dist. LEXIS 13395, 1998 WL 547009
CourtDistrict Court, E.D. Texas
DecidedJuly 24, 1998
DocketNo. 4:96CV385
StatusPublished
Cited by5 cases

This text of 181 F.R.D. 341 (Ruffu v. Johnson & Johnson, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ruffu v. Johnson & Johnson, Inc., 181 F.R.D. 341, 1998 U.S. Dist. LEXIS 13395, 1998 WL 547009 (E.D. Tex. 1998).

Opinion

MEMORANDUM OPINION and ORDER

PAUL N. BROWN, District Judge.

This case involves claims brought by Plaintiffs based on the Racketeering Influenced and Corrupt Organizations Act (“RICO”), 18 U.S.C. § 1961, et seq., the New Jersey Consumer Fraud Act, and common law claims for unjust enrichment and negligence. Pending before the Court is Plaintiffs’ Motion for Class Certification.

Introduction

Plaintiffs are consumers who purchased Retin-A for the treatment of wrinkles from February 1, 1983 through December 1, 1995. Retin-A was approved for the treatment of wrinkles in December, 1995. Prior to this approval, FDA regulations prevented Johnson & Johnson as the maker of Retin-A from promoting or marketing Retin-A for use for which it had not been approved. Although FDA rules do not restrict exchange of scientific information concerning a new drug or new use in the media, a drug manufacturer [342]*342cannot exercise substantive control in the dissemination of this information.

Defendants are (1) Johnson & Johnson Incorporated (“J & J”); (2) Ortho Pharmaceutical Corporation (“Ortho”), a subsidiary of J & J; (3) Alfred M. Kligman (“Kligman”), the person who discovered Retin-A, (4) Manning, Selvage, & Lee, Incorporated; and (5) The Softness Group. The last two Defendants are public relations firms hired by J & J.

Plaintiffs allege that Defendants engaged in a deceptive campaign by which J & J, acting through Ortho, controlled dissemination of information regarding Retin-A’s effectiveness in treating wrinkles while making it appear that this information came from independent sources. Plaintiffs are asserting claims based on RICO, the New Jersey Consumer Fraud Act, and common law claims for unjust enrichment and negligence. Plaintiffs seek to certify as a class “all persons who purchased Retin-A as an anti-wrinkle medication from February 1, 1983 through December 1, 1995” pursuant to Federal Rule of Civil Procedure 23.

PLAINTIFFS’ MOTION

I. RULE 23

A. The Applicable Law

Plaintiffs seeking to certify a class have the burden to establish that the requisites for certification are established. Byes v. Tele-check Recovery Servs. Inc., 173 F.R.D. 421, 423 (E.D.La.1997). To be certified, the potential class must satisfy all of the requirements of Federal Rule of Civil Procedure 23(a) and at least one of the subsections of Rule 23(b).

Rule 23(a) provides that:

One or more members of a class may sue or be sued as representative parties on behalf of all only if (1) the class is so numerous that joinder of all members is impracticable, (2) there are questions of law or fact common to the class, (3) the claims or defenses of the representative parties are typical of the claims or defenses of the class, and (4) the representative parties will fairly and adequately protect the interests of the class.

To be certified, this action must also satisfy one of the requirements of Rule 23(b). Plaintiffs argue that the class meets the requirements of Rule 23(b)(3) which states that a class action is maintainable if the court finds that the questions of law or fact common to the members of the class predominate over any questions affecting only individual members, and that a class action is superior to other available methods for the fair and efficient adjudication of the controversy. Because the Court finds Plaintiffs unable to meet the requirements of Rule 23(b)(3), the Court need not address Rule 23(a).

B. Rule 23(b)(3)

1. Do Questions of Law or Fact Common to the Class Predominate Over Any Questions Affecting Only Individual Members?

Plaintiffs argue that common questions predominate because Defendants’ conduct is the significant issue and is subject to generalized proof at trial. Plaintiffs contend that the claims in this case do not require proof of typically individualized issues such as specific misrepresentations, materiality, or reliance.

Defendants contend that common questions of law and fact do not predominate because it cannot be assumed that all RetinA purchasers were exposed to or influenced by any of the media accounts allegedly attributable to Defendants in their decision to purchase Retin-A for the treatment of wrinkles.

The parties contest whether proof of individualized conduct is necessary to prove the predicate acts required to establish liability under RICO and whether individualized proof will be necessary for Plaintiffs to establish standing under RICO. The Court will address each of these arguments separately.

(a) The Elements of A RICO Claim

To establish entitlement to recovery under RICO, Plaintiffs must plead and prove that Defendants, through the commission of two or more acts, known as predicate acts, direct[343]*343ly or indirectly invested in or maintained an interest in, or participated in an enterprise which affected interstate commerce. 18 U.S.C. §§ 1961-1968.

(1) The Alleged Predicate Acts — Elements of Mail and Wire Fraud

Plaintiffs are basing their legal theory of liability under RICO on a type of mail and wire fraud, a “scheme to defraud.” Under this theory, Plaintiffs contend that they only need to prove that Defendants’ conduct was reasonably calculated to deceive the ordinary person, regardless of whether any fraudulent statements were made. United States v. Pepper, 51 F.3d 469, 472 (5th Cir.1995); Abell v. Potomac Ins. Co., 858 F.2d 1104, 1130 (5th Cir.1988), vacated on other grounds, 492 U.S. 914, 109 S.Ct. 3236, 106 L.Ed.2d 584 (1989). Plaintiffs argue that, under this theory, it does not matter that neither the First Amended Complaint nor the Plaintiffs have identified specific false statements or misleading media accounts. Further, reliance and materiality are not elements of either wire or mail fraud. Abell, 858 F.2d at 1129.

To prove mail fraud, Plaintiffs must prove that

(1) the defendant participated in some scheme or artifice to defraud, (2) the defendant or someone associated with the scheme used the mails or “caused” the mails to be used, and (3) the use of the mails was for the purpose of executing the scheme.

Id. The same elements apply to wire fraud. United States v. Dula, 989 F.2d 772, 778 (5th Cir.1993).

The Court agrees with Plaintiffs that, at this time, materiality and reliance are not elements of a claim for either wire or mail fraud brought pursuant to RICO. Abell, 858 F.2d at 1129;

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Neurontin Marketing & Sale Practices Litigation
244 F.R.D. 89 (D. Massachusetts, 2007)
Corley v. Entergy Corp.
220 F.R.D. 478 (E.D. Texas, 2004)
Hasken v. City of Louisville
213 F.R.D. 280 (W.D. Kentucky, 2003)
Marquis v. Tecumseh Products Co.
206 F.R.D. 132 (E.D. Michigan, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
181 F.R.D. 341, 1998 U.S. Dist. LEXIS 13395, 1998 WL 547009, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ruffu-v-johnson-johnson-inc-txed-1998.